Skip to content
healthcare.dev

Oxybutynin Chloride

NDC 65162-373, Oxybutynin Chloride, tablet, extended release, from Amneal Pharmaceuticals LLC.

Product NDC
65162-373
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204010
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65162-373 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYBUTYNIN CHLORIDE15 mg/1

Pharmacologic classes

Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
65162-373-036516203730330 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-373-03)
65162-373-096516203730990 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-373-09)
65162-373-1065162037310100 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-373-10)
65162-373-2565162037325250 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-373-25)
65162-373-5065162037350500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-373-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/53924eba-1919-4203-9a1e-d57dfdd3b963

Use it

Look up 65162-373 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65162-373 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65162-373. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.